General Information of the Compound
| Compound ID |
CP0316257
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-Morpholin-4-yl-chromen-2-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
2H-1-Benzopyran-2-one, 4-(4-morpholinyl)-
4-(4-morpholinyl)-2H-chromen-2-one
4-Morpholin-4-yl-chromen-2-one
4-morpholin-4-ylchromen-2-one
4-morpholino-2H-chromen-2-one
4-morpholinyl coumarin
65625-83-4
AC1LFJN6
AI-204/31682008
AKOS000639877
BAS 01256112
BDBM50159613
BIM-0022285.P001
CBMicro_022351
CCG-9410
CHEMBL367262
CTK1I2254
DTXSID30355510
HMS2490I17
MCULE-8859511318
MLS000526002
MolPort-001-959-554
Oprea1_628619
Oprea1_860966
SCHEMBL11450752
SMR000116476
SR-01000312410
ST50008215
ZINC312514
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H13NO3
|
||||||||||||||||||
| Molecular Weight |
231.251
|
||||||||||||||||||
| Canonical SMILES |
O=c1cc(N2CCOCC2)c2ccccc2o1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H13NO3/c15-13-9-11(14-5-7-16-8-6-14)10-3-1-2-4-12(10)17-13/h1-4,9H,5-8H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
YJXJQEJDZPLPTQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound